Disparities Details by Sex for 2016
IID-11.3 : Adolescents receiving 1+ doses of meningococcal vaccine by age 13–15 years (percent)
This chart compares rates by population.
Error Bar (I) represents the 95% confidence interval.
Additional footnotes may apply to these data. Please refer to footnotes below the data table for further information.
See also Disparities Overview by Sex for IID-11.3
IID-11.3 Increase the vaccination coverage level of 1 dose meningococcal conjugate vaccine for adolescents by age 13 to 15 years
Adolescents receiving 1+ doses of meningococcal vaccine by age 13–15 years (percent)
Data are subject to revision and may have changed since a previous release.
Unless noted otherwise, any age-adjusted data are adjusted using the year 2000 standard population.
Data are not available or not collected for populations not shown.
CI: 95% confidence interval.
- The better group rate for this objective, 82.7%, was attained by the female population.
- The worse group rate for this objective, 80.9%, was attained by the male population.
- The absolute difference (or range) between the best and worst group rates was 1.8 percentage points.
- The best group rate was <1.100 times the worst group rate.
The female population achieved the better group rate for this objective, 82.7%.
The better group rate was <1.1 times the rate for the male population.